Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Beuselinck

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Acta Clinica Belgica|January 1, 1994
Ciprofloxacin-induced hypersensitivity vasculitisB Beuselinck, O Devuyst
Acta Clinica Belgica|January 10, 2006
Multicystic pulmonary metastases of endometrial carcinomaB Beuselinck, B Beuselink, K Weytjens, et al.
Acta Clinica Belgica|August 24, 2013
Pain management in palliative cancer patients: a prospective observational study on the use of high dosages of transdermal buprenorphineP M J Clement, B Beuselinck, P G Mertens, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2011
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumoursM J A de Jonge, H Dumez, J J E M Kitzen, et al.
Breast Cancer Research and Treatment|May 17, 2018
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancerG Hoste, K Punie, H Wildiers, et al.
Acta Clinica Belgica|January 29, 2011
A case series of embryonal rhabdomyosarcoma of the head and neck in adultsJ Wagemans, B Beuselinck, S Nuyts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinibB Beuselinck, S Oudard, O Rixe, et al.
Bone Reports|July 2, 2026
MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitorsG Mammone, R Coropciuc, T Van den Wyngaert, et al.
British Journal of Cancer|November 8, 2012
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastasesB Beuselinck, P Wolter, A Karadimou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinomaR Elaidi, A Harbaoui, B Beuselinck, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Acta Clinica Belgica|January 1, 1994
Ciprofloxacin-induced hypersensitivity vasculitisB Beuselinck, O Devuyst
Acta Clinica Belgica|January 10, 2006
Multicystic pulmonary metastases of endometrial carcinomaB Beuselinck, B Beuselink, K Weytjens, et al.
Acta Clinica Belgica|August 24, 2013
Pain management in palliative cancer patients: a prospective observational study on the use of high dosages of transdermal buprenorphineP M J Clement, B Beuselinck, P G Mertens, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2011
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumoursM J A de Jonge, H Dumez, J J E M Kitzen, et al.
Breast Cancer Research and Treatment|May 17, 2018
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancerG Hoste, K Punie, H Wildiers, et al.
Acta Clinica Belgica|January 29, 2011
A case series of embryonal rhabdomyosarcoma of the head and neck in adultsJ Wagemans, B Beuselinck, S Nuyts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinibB Beuselinck, S Oudard, O Rixe, et al.
Bone Reports|July 2, 2026
MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitorsG Mammone, R Coropciuc, T Van den Wyngaert, et al.
British Journal of Cancer|November 8, 2012
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastasesB Beuselinck, P Wolter, A Karadimou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinomaR Elaidi, A Harbaoui, B Beuselinck, et al.
Pageof 3